Publications
Explore our research contributions through peer-reviewed publications, conference presentations, and scholarly works that advance scientific knowledge.
Publication Statistics
Filter Publications
Select journals from the dropdown to filter publications
Showing 197 of 197 publications
2024
9 publicationsRadiomics and PD-L1 expression predict immunotherapy benefits in patients with head and neck squamous cell carcinoma
Sim Y, Sohn B, Kim S, Kim HR, Hong MH, Kim J, Lee SK, Lim SM
Radiomics and PD-L1 expression predict immunotherapy benefits in patients with head and neck squamous cell carcinoma
Sim Y, Sohn B, Kim S, Kim HR, Hong MH, Kim J, Lee SK, Lim SM
Real-World Outcomes with Lurbinectedin in Second Line and Beyond for Extensive Stage Small Cell Lung Cancer in Korea
Shim JS, Kim Y, Yuh T, Lee JB, Kim HR, Hong MH, Cho BC, Lim SM
Analysis of Response and Progression Patterns of Tyrosine Kinase Inhibitors in Recurrent or Metastatic Adenoid Cystic Carcinoma: A Post Hoc Analysis of Two KCSG Phase II Trials
Kim Y, Keam B, Kang EJ, Kim JS, Kim HR, Lee KW, Kwon JH, Lee KE, Yang Y, Choi YH, Kim MK, Ji JH, Yun T, Choi MY, Lee KH, Kim SB, Ahn MJ
Neoadjuvant chemotherapy followed by definitive local treatment in locally advanced sinonasal squamous cell carcinoma
Kim J, Hong MH, Kim HR, Lim SM, Kim CG, Kim DH, Sim NS, Hong HJ, Koh YW, Kim SH, Wee CW, Lee CG, Keum KC, Kim CH, Kim KH
Personalized Biomarker-Based Umbrella Trial for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: KCSG HN 15-16 TRIUMPH Trial
Keam B, Hong MH, Shin SH, Heo SG, Kim JE, Ahn HK, Lee YG, Park KU, Yun T, Lee KW, Kim SB, Lee SC, Kim MK, Cho SH, Oh SY, Park SG, Hwang S, Nam BH, Kim S, Kim HR, Hwan JY
Lazertinib in EGFR-Variant Non-Small Cell Lung Cancer With CNS Failure to Prior EGFR Tyrosine Kinase Inhibitors: A Nonrandomized Controlled Trial
Hong MH, Choi YJ, Ahn HK, Lim SM, Keam B, Kim DW, Kim TM, Youk J, Kim YJ, Hwang S, Kim S, Kim JW, Kim HR, Kang JH
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with oncogene-addicted metastatic non-small-cell lung cancer
Lee SH, Menis J, Kim TM, Kim HR, Zhou C, Kurniawati SA, Prabhash K, Hayashi H, Lee DD-W, Imasa MS, Teh YL, Yang JC-H, Reungwetwattana T, Sriuranpong V, Wu C-E, Ang Y, Sabando M, Thiagarajan M, Mizugaki H, Noronha V, Yulianti M, Zhang L, Smyth E, Yoshino T, Park JO, Pentheroudakis G, Park S, Peters S, Ahn JB, Popat S
A conserved pilin from uncultured gut bacterial clade TANB77 enhances cancer immunotherapy
Kim CY, Park DJ, Ahn BC, Baek SB, Hong MH, Nguyen LT, Hwang SH, Kim N, Podlesny D, Orakov A, Schudoma C, Robbani SM, Shim HS, Yoon HI, Lee CY, Park SY, Yong D, Han M, Bork P, Kim BC, Ha SJ, Kim HR, Lee I
2023
11 publicationsThe prognostic value of comprehensive geriatric assessment on the management of older patients with small cell lung cancer
Chun YJ, Kim KJ, Lee JY, Choi JW, Kim TH, Kim HR, Cho BC, Hong MH, Kim CO
Journal: Korean Journal of Internal Medicine
Volume: ,
Medium ImpactComparison of Treatment Patterns and Clinical Outcomes by Gender in Locally Advanced Head and Neck Squamous Cell Carcinoma (KCSG HN13-01)
Lee YG, Kang EJ, Keam B, Choi JH, Kim JS, Park KU, Lee KE, Lee KW, Kim MK, Ahn HK, Shin SH, Kim HR, Kim SB, Kim HJ, Yun HJ
The Role of Adjuvant Therapy Following Surgical Resection of Small Cell Lung Cancer: A Multi-Center Study
Park SY, Park S, Lee GD, Kim HK, Choi S, Kim HR, Kim YH, Kim DK, Park SI, Hong TH, Choi YS, Kim J, Cho JH, Shim YM, Zo JI, Na KJ, Park IK, Kang CH, Kim YT, Park BJ, Lee CY, Lee JG, Kim DJ, Paik HC
Journal: Cancer Research and Treatment
Volume: 55(1), 94-102
Medium ImpactAsian Subgroup Analysis of the Randomized Phase 3 CROWN Study of First-Line Lorlatinib Versus Crizotinib in Advanced ALK-Positive NSCLC
Zhou Q, Soo RA, Chang GC, Chiu CH, Hayashi H, Kim SW, Teraoka S, Goto Y, Zhou J, Ho-Fun Lee V, Kim DW, Han B, Ho JC, Lin CC, Lu S, Polli A, Calella AM, Martini JF, Wong CH, Mok T, Kim HR, Wu YL
Journal: JTO Clinical and Research Reports
Volume: 4(5), 100499
DOI:10.1016/j.jtocrr.2023.100499
High ImpactOutcomes of an Acute Palliative Care Unit at a Comprehensive Cancer Center in Korea
Lee SW, Kwon JH, Beom SH, Shin SJ, Kim HS, Rha SY, Jung M, Sohn JH, Ahn JB, Chung HC, Kim GM, Kim HR, Kang BD, Hu YJ, Choi HJ
Lazertinib in pretreated EGFR T790M-mutated advanced non-small cell lung cancer: A real-world multicenter study
Kim H, Ahn BC, Lee J, Lee JB, Hong MH, Kim HR, Cho BC, Lim SM
Dynamic change of immune phenotype assessed by AI-powered analysis of tumor-infiltrating lymphocytes during neoadjuvant durvalumab with or without tremelimumab in head and neck squamous cell carcinoma
Kim H, Koh YW, Hong HJ, Kim DH, Sim NS, Hong MH, Kim CG, Lee C, Kim KH, Kang M, Song H, Oum C, Kim S, Lim Y, Ock CY, Yoon SO
Conference:
Location:
Type:
Personalized Biomarker-Based Umbrella Trial for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: KCSG HN 15-16 TRIUMPH Trial
Keam B, Hong MH, Shin SH, Heo SG, Kim JE, Ahn HK, Lee YG, Park KU, Yun T, Lee KW, Kim SB, Lee SC, Kim MK, Cho SH, Oh SY, Park SG, Hwang S, Nam BH, Kim S, Kim HR, Hwan JY
Conference:
Location:
Type:
Patient-Reported Health-Related Quality of Life in KEYNOTE-604: Pembrolizumab or Placebo Added to Etoposide and Platinum as First-Line Therapy for Extensive-Stage SCLC
Kim HR, Awad MM, Navarro A, Gottfried M, Peters S, Csoszi T, Cheema PK, Rodriguez-Abreu D, Wollner M, Yang JC, Mazieres J, Orlandi FJ, Luft A, Gumus M, Kato T, Kalemkerian GP, Luo Y, Santorelli ML, Pietanza MC, Rudin CM
Journal: JTO Clinical and Research Reports
Volume: 4(11), 100572
DOI:10.1016/j.jtocrr.2023.100572
High ImpactA randomized Phase 2 study to compare erlotinib with or without bevacizumab in previously untreated patients with advanced non-small cell lung cancer with EGFR mutation
Lee Y, Kim HR, Hong MH, Lee KH, Park KU, Lee GK, Kim HY, Lee SH, Lim KY, Yoon SJ, Cho BC, Han JY
Patient-Reported Health-Related Quality of Life in KEYNOTE-604: Pembrolizumab or Placebo Added to Etoposide and Platinum as First-Line Therapy for Extensive-Stage SCLC
Kim HR, Awad MM, Navarro A, Gottfried M, Peters S, Csoszi T, Cheema PK, Rodriguez-Abreu D, Wollner M, Yang JC, Mazieres J, Orlandi FJ, Luft A, Gümüs M, Kato T, Kalemkerian GP, Luo Y, Santorelli ML, Pietanza MC, Rudin CM
Journal: JTO Clinical and Research Reports
Volume: 4(11), 100572
DOI:10.1016/j.jtocrr.2023.100572
High Impact2022
17 publicationsPredicting treatment outcomes using 18F-FDG PET biomarkers in patients with non-small-cell lung cancer receiving chemoimmunotherapy
Kim CG, Hwang SH, Kim KH, Yoon HI, Shim HS, Lee JH, Han Y, Ahn BC, Hong MH, Kim HR, Cho BC, Cho A, Lim SM
Journal: Therapeutic Advances in Medical Oncology
Volume: 14, 17588359211068732
Medium ImpactMolecular landscape of osimertinib resistance in patients and patient-derived preclinical models
Lim SM, Yang SD, Lim S, Heo SG, Daniel S, Markovets A, Minoo R, Pyo KH, Yun MR, Hong MH, Kim HR, Cho BC
Journal: Therapeutic Advances in Medical Oncology
Volume: 14, 17588359221079125
Medium ImpactNivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma
Doki Y, Ajani JA, Kato K, Xu J, Wyrwicz L, Motoyama S, Ogata T, Kawakami H, Hsu CH, Adenis A, El Hajbi F, Di Bartolomeo M, Braghiroli MI, Holtved E, Ostoich SA, Kim HR, Ueno M, Mansoor W, Yang WC, Liu T, Bridgewater J, Makino T, Xynos I, Liu X, Lei M, Kondo K, Patel A, Gricar J, Chau I, Kitagawa Y; CheckMate 648 Trial Investigators
Journal: The New England Journal of Medicine
Volume: 386(5), 449-462
High ImpactDisproportional enrichment of FoxP3+ CD4+ regulatory T cells shapes a suppressive tumour microenvironment in head and neck squamous cell carcinoma
Park S, Kim CG, Kim D, Hong MH, Choi EC, Kim SH, Park YM, Kim J, Yoon SO, Kim G, Shin S, Kim K, Koh YW, Ha SJ, Kim HR
Journal: Clinical and Translational Medicine
Volume: 12(3), e753
Medium ImpactThe Development of AXL Inhibitors in Lung Cancer: Recent Progress and Challenges
Sang YB, Kim JH, Kim CG, Hong MH, Kim HR, Cho BC, Lim SM
Journal: Frontiers in Oncology
Volume: 12, 811247
Medium ImpactGenomic Landscape of Non-Small Cell Lung Cancer (NSCLC) in East Asia Using Circulating Tumor DNA (ctDNA) in Clinical Practice
Cho BC, Loong HHF, Tsai CM, Teo MLP, Kim HR, Lim SM, Jain S, Olsen S, Park K
Journal: Current Oncology
Volume: 29(3), 2154-2164
Medium ImpactAn Overview of Surgical Treatment of Thymic Epithelial Tumors in Korea: A Retrospective Multicenter Analysis
Lee JO, Lee GD, Kim HR, Kim DK, Park SI, Cho JH, Kim HK, Choi YS, Kim J, Shim YM, Park S, Park IK, Kang CH, Kim YT, Park SY, Lee CY, Lee JG, Kim DJ, Paik HC; Korean Association for Research on the Thymus
Journal: Journal of Chest Surgery
Volume: 55(2), 126-142
Low ImpactContinuous centrifugal microfluidics (CCM) isolates heterogeneous circulating tumor cells via full automation
Woo HJ, Kim SH, Kang HJ, Lee SH, Lee SJ, Kim JM, Gurel O, Kim SY, Roh HR, Lee J, Park Y, Shin HY, Shin YI, Lee SM, Oh SY, Kim YZ, Chae JI, Lee S, Hong MH, Cho BC, Lee ES, Pantel K, Kim HR, Kim MS
Journal: Theranostics
Volume: 12(8), 3676-3689
Medium ImpactReal World Characteristics and Clinical Outcomes of HER2-Mutant Non-Small Cell Lung Cancer Patients Detected by Next-Generation Sequencing
Ahn BC, Han YJ, Kim HR, Hong MH, Cho BC, Lim SM
Journal: Cancer Research and Treatment
Volume: ,
Medium ImpactEfficacy and Safety of Brigatinib Compared With Crizotinib in Asian vs. Non-Asian Patients With Locally Advanced or Metastatic ALK-Inhibitor-Naive ALK+ Non-Small Cell Lung Cancer: Final Results From the Phase III ALTA-1L Study
Ahn MJ, Kim HR, Yang JCH, Han JY, Li JY, Hochmair MJ, Chang GC, Delmonte A, Lee KH, Campelo RG, Gridelli C, Spira AI, Califano R, Griesinger F, Ghosh S, Felip E, Kim DW, Liu Y, Zhang P, Popat S, Camidge DR
Journal: Clinical Lung Cancer
Volume: 23(8), 720-730
Medium ImpactTreatment Patterns, Clinical Outcomes and Health Care Resource Utilisation in Patients with EGFR-mutated Metastatic Non-Small Cell Lung Cancer: A Real-World Study in South Korea
Molife C, Cho JM, Lapthorn J, Kang MJ, D’yachkova Y, Kim S, Colman S, Kim S, Szende A, Park JH, Ahn HK, Hong MH, Taipale KL, Kim HR
Journal: Drugs - Real World Outcomes
Volume: ,
Medium ImpactRole of postoperative radiotherapy in resected adenoid cystic carcinoma of the head and neck
Choi SH, Yang AJ, Yoon SO, Kim HR, Hong MH, Kim SH, Choi EC, Keum KC, Lee CG
Journal: Radiation Oncology
Volume: 17, 197
Medium ImpactTreatment outcomes and radiotherapy deintensification strategies in human papillomavirus-associated tonsil cancer
Lee J, Kim K, Kim KH, Keum KC, Kim HR, Hong MH, Choi EC, Kim SH, Koh YW, Lee CG
Journal: Radiation Oncology
Volume: 17, 209
Medium ImpactPlasma tumor mutation burden is associated with clinical benefit in patients with non-small cell lung cancer treated with anti-programmed death-1 monotherapy
Lee JB, Park HS, Choi SJ, Heo SG, An HJ, Kim HR, Hong MH, Lim SM, Chang K, Quinn K, Odegaard J, Shim BY, Cho BC
Journal: Therapeutic Advances in Medical Oncology
Volume: 14, 17588359221141761
Medium ImpactLymphocyte dynamics during and after chemo-radiation correlate to dose and outcome in stage III NSCLC patients undergoing maintenance immunotherapy
Cho Y, Kim Y, Chamseddine I, Lee WH, Kim HR, Lee IJ, Hong MH, Cho BC, Lee CG, Cho S, Kim JS, Yoon HI, Grassberger C
Journal: Radiotherapy and Oncology
Volume: 168, 1-7
Medium ImpactYH29407 with anti-PD-1 ameliorates anti-tumor effects via increased T cell functionality and antigen presenting machinery in the tumor microenvironment
Kim DK, Synn CB, Yang SM, Kang S, Baek S, Oh SW, Lee GJ, Kang HW, Lee YS, Park JS, Kim JH, Byeon Y, Kim YS, Lee DJ, Kim HW, Park JD, Lee SS, Lee JY, Lee JB, Kim CG, Hong MH, Lim SM, Kim HR, Pyo KH, Cho BC
Journal: Frontiers in Chemistry
Volume: 10, 998013
Medium ImpactA Phase 1/2 Study of Lazertinib 240 mg in Patients With Advanced EGFR T790M-Positive NSCLC After Previous EGFR Tyrosine Kinase Inhibitors
Cho BC, Han JY, Kim SW, Lee KH, Cho EK, Lee YG, Kim DW, Kim JH, Lee GW, Lee JS, Shim BY, Kim JS, Chun SH, Lee SS, Kim HR, Hong MH, Ahn JS, Sun JM, Lee Y, Lee DH, Kang JA, Lee N, Kwon MJ, Espenschied C, Yablonovitch A, Ahn MJ
Journal: Journal of Thoracic Oncology
Volume: 17(4), 558-567
High Impact2021
26 publicationsHuman reference gut microbiome catalog including newly assembled genomes from under-represented Asian metagenomes
Kim CY, Lee M, Yang S, Kim K, Yong D, Kim HR, Lee I
Journal: GENOME MEDICINE
Volume: ,
High ImpactA phase II study of poziotinib in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
Lee JH, Heo SG, Ahn BC, Hong MH, Cho BC, Lim SM, Kim HR
Journal: CANCER MEDICINE
Volume: ,
Low ImpactOutcomes and Biomarkers of Immune Checkpoint Inhibitor Therapy in Patients with Refractory Head and Neck Squamous Cell Carcinoma: KCSG HN18-12
Lee YG, Chang H, Keam B, Chun SH, Park J, Park KU, Shin SH, An HJ, Lee KE, Lee KW, Kim HR, Kim SB, Ahn MJ, Hwang IG
Journal: CANCER RESEARCH AND TREATMENT
Volume: ,
Medium ImpactNivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451
Owonikoko TK, Park K, Govindan R, Ready N, Reck M, Peters S, Dakhil SR, Navarro A, Rodríguez-Cid J, Schenker M, Lee JS, Gutierrez V, Percent I, Morgensztern D, Barrios CH, Greillier L, Baka S, Patel M, Lin WH, Selvaggi G, Baudelet C, Baden J, Pandya D, Doshi P, Kim HR
Journal: JOURNAL OF CLINICAL ONCOLOGY
Volume: ,
High ImpactClinical Insights Into Novel Immune Checkpoint Inhibitors
Lee JB, Ha SJ, Kim HR
Journal: FRONTIERS IN PHARMACOLOGY
Volume: ,
Medium ImpactHyperprogressive disease during PD-1 blockade in patients with advanced hepatocellular carcinoma
Qian Li, Jingjing Han, Yonglin Yang, Yu Chen
Journal: JOURNAL OF HEPATOLOGY
Volume: ,
High ImpactDynamic changes in circulating PD-1(+)CD8(+)T lymphocytes for predicting treatment response to PD-1 blockade in patients with non-small-cell lung cancer
Chang Gon Kim, Min Hee Hong, Kyung Hwan Kim, In-Ho Seo, Beung-Chul Ahn, Kyoung-Ho Pyo, Chun-Bong Synn, Hong In Yoon, Hyo Sup Shim, Yong Il Lee, Seong Jin Choi, Yun Jeong Lee, Ellen Janine Kim, Youngun Kim, Jeong-Eun Kwak, Jaehyung Jung, Su-Hyung Park, Soonmyung Paik, Eui-Cheol Shin, Hye Ryun Kim
Journal: EUROPEAN JOURNAL OF CANCER
Volume: ,
Medium ImpactOverexpression of poliovirus receptor is associated with poor prognosis in head and neck squamous cell carcinoma patients
Lim SM, Hong MH, Ha SJ, Hwang D, Chae S, Koh YW, Choi EC, Kim SH, Kim DH, Yoon SO, Kim HR
Journal: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Volume: ,
Low ImpactClinical Perspectives to Overcome Acquired Resistance to Anti-Programmed Death-1 and Anti-Programmed Death Ligand-1 Therapy in Non-Small Cell Lung Cancer
Lee YJ, Lee JB, Ha SJ, Kim HR
Journal: MOLECULES AND CELLS
Volume: ,
Medium ImpactClinical decision support algorithm based on machine learning to assess the clinical response to anti-programmed death-1 therapy in patients with non-small-cell lung cancer
Ahn BC, So JW, Synn CB, Kim TH, Kim JH, Byeon Y, Kim YS, Heo SG, Yang SD, Yun MR, Lim S, Choi SJ, Lee W, Kim DK, Lee EJ, Lee S, Lee DJ, Kim CG, Lim SM, Hong MH, Cho BC, Pyo KH, Kim HR
Journal: EUROPEAN JOURNAL OF CANCER
Volume: ,
Medium ImpactDistinct Characteristics and Clinical Outcomes to Predict the Emergence of MET Amplification in Patients with Non-Small Cell Lung Cancer Who Developed Resistance after Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
Ahn BC, Lee JH, Kim MH, Pyo KH, Lee CK, Lim SM, Kim HR, Cho BC, Hong MH
Journal: CANCERS
Volume: ,
Medium ImpactGenetic Analysis and Operative Outcomes in Patients with Oncogene-Driven Advanced NSCLC Treated with Cytoreductive Surgery as a Component of Local Consolidative Therapy
Park BJ, Shim HS, Lee CY, Lee JG, Kim HR, Lee SH, Hong MH, Park SY
Journal: CANCERS
Volume: ,
Medium ImpactNivolumab with carboplatin, paclitaxel, and bevacizumab for first-line treatment of advanced nonsquamous non-small-cell lung cancer
Sugawara S, Lee JS, Kang JH, Kim HR, Inui N, Hida T, Lee KH, Yoshida T, Tanaka H, Yang CT, Nishio M, Ohe Y, Tamura T, Yamamoto N, Yu CJ, Akamatsu H, Namba Y, Sumiyoshi N, Nakagawa K
Journal: ANNALS OF ONCOLOGY
Volume: ,
High ImpactDysregulation of T FH-B-T RM lymphocyte cooperation is associated with unfavorable anti-PD-1 responses in EGFR-mutant lung cancer
Cho JW, Park S, Kim G, Han H, Shim HS, Shin S, Bae YS, Park SY, Ha SJ, Lee I, Kim HR
Journal: NATURE COMMUNICATIONS
Volume: ,
High ImpactPhase 2 study of TAS-117, an allosteric akt inhibitor in advanced solid tumors harboring phosphatidylinositol 3-kinase/v-akt murine thymoma viral oncogene homolog gene mutations
Lee JB, Jung M, Beom SH, Kim GM, Kim HR, Choi HJ, Sohn JH, Ahn JB, Rha SY, Chung HC
Journal: INVESTIGATIONAL NEW DRUGS
Volume: ,
Low ImpactIntracranial failure after hippocampal-avoidance prophylactic cranial irradiation in limited-stage small-cell lung cancer patients
Theresa A Cook, Matthew R Hoffmann, Amie J Ross, Kirsty J Turnbull, Justin Westhuyzen, Noel J Aherne
Journal: SCIENTIFIC REPORTS
Volume: ,
Medium ImpactOverexpression of PVR and PD-L1 and its association with prognosis in surgically resected squamous cell lung carcinoma
Jii Bum Lee, Min Hee Hong, Seong Yong Park, Sehyun Chae, Daehee Hwang, Sang-Jun Ha, Hyo Sup Shim, Hye Ryun Kim
Journal: SCIENTIFIC REPORTS
Volume: ,
Medium ImpactPostoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Advanced Oral Cavity Cancer in the Era of Modern Radiation Techniques
Tae Hyung Kim, In-Ho Cha, Eun Chang Choi, Hye Ryun Kim, Hyung Jun Kim, Se-Heon Kim, Ki Chang Keum, Chang Geol Lee
Journal: FRONTIERS IN ONCOLOGY
Volume: ,
Medium ImpactA randomised phase 2b study comparing the efficacy and safety of belotecan vs. topotecan as monotherapy for sensitive-relapsed small-cell lung cancer
Jin-Hyoung Kang, Ki-Hyeong Lee, Dong-Wan Kim, Sang-We Kim, Hye Ryun Kim, Joo-Hang Kim, Jin-Hyuk Choi, Ho Jung An, Jin-Soo Kim, Joung-Soon Jang, Bong-Seog Kim, Heung Tae Kim
Journal: BRITISH JOURNAL OF CANCER
Volume: ,
Medium ImpactAnalyses of CNS Response to Osimertinib in Patients with T790M-Positive Advanced NSCLC from ASTRIS Korean Subset, Open-Label Real-World Study
Ahn BC, Kim JH, Pyo KH, Lim SM, Hong MH, Kim HR, Cho BC
Journal: CANCERS
Volume: ,
Medium ImpactRole and Function of O-GlcNAcylation in Cancer.
Lee JB, Pyo KH, Kim HR
Distinct exhaustion features of T lymphocytes shape the tumor-immune microenvironment with therapeutic implication in patients with non-small-cell lung cancer.
Kim CG, Kim G, Kim KH, Park S, Shin S, Yeo D, Shim HS, Yoon HI, Park SY, Ha SJ, Kim HR
Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinoma.
Jin N, Keam B, Cho J, Lee MJ, Kim HR, Torosyan H, Jura N, Ng PK, Mills GB, Li H, Zeng Y, Barbash Z, Tarcic G, Kang H, Bauman JE, Kim MO, VanLandingham NK, Swaney DL, Krogan NJ, Johnson DE, Grandis JR
Therapeutic Singing as a Swallowing Intervention in Head and Neck Cancer Patients With Dysphagia.
Jo S, Yeo MS, Shin YK, Shin KH, Kim SH, Kim HR, Kim SJ, Cho SR
Brigatinib Versus Crizotinib in ALK Inhibitor-Naive Advanced ALK-Positive NSCLC: Final Results of Phase 3 ALTA-1L Trial.
Camidge DR, Kim HR, Ahn MJ, Yang JCH, Han JY, Hochmair MJ, Lee KH, Delmonte A, Garcia Campelo MR, Kim DW, Griesinger F, Felip E, Califano R, Spira AI, Gettinger SN, Tiseo M, Lin HM, Liu Y, Vranceanu F, Niu H, Zhang P, Popat S
Pan-Asian adaptation of the EHNS-ESMO-ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck.
Keam B, Machiels JP, Kim HR, Licitra L, Golusinski W, Gregoire V, Lee YG, Belka C, Guo Y, Rajappa SJ, Tahara M, Azrif M, Ang MK, Yang MH, Wang CH, Ng QS, Wan Zamaniah WI, Kiyota N, Babu S, Yang K, Curigliano G, Peters S, Kim TW, Yoshino T, Pentheroudakis G
2020
21 publicationsPhase 2 study of afatinib among patients with recurrent and/or metastatic esophageal squamous cell carcinoma
Fei Yan, Jingni Zhu, Qibing Wu, Yuanyuan Ren, Xinnian Yu, Zijian Sun, Yang Liu, Changjiang Sun, Yan Sun
Journal: CANCER
Volume: ,
High ImpactTumor-Infiltrating Regulatory T-cell Accumulation in the Tumor Microenvironment Is Mediated by IL33/ST2 Signaling
Jimin Son, Jae-Won Cho, Hyo Jin Park, Jihyun Moon, Seyeon Park, Hoyoung Lee, Jeewon Lee, Gamin Kim, Su-Myeong Park, Sergio A Lira, Andrew N Mckenzie, Hye Young Kim, Cheol Yong Choi, Yong Taik Lim, Seong Yong Park, Hye Ryun Kim, Su-Hyung Park, Eui-Cheol Shin, Insuk Lee, Sang-Jun Ha
Journal: CANCER IMMUNOLOGY RESEARCH
Volume: ,
High ImpactThe feasibility and safety of radical esophagectomy in patients receiving neoadjuvant chemoradiotherapy with pembrolizumab for esophageal squamous cell carcinoma
Seong Yong Park, Min Hee Hong, Hye Ryun Kim, Chang Geol Lee, Jae Ho Cho, Byoung Chul Cho, Dae Joon Kim
Journal: JOURNAL OF THORACIC DISEASE
Volume: ,
Low ImpactBrigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial
D Ross Camidge, Hye Ryun Kim, Myung-Ju Ahn, James C H Yang, Ji-Youn Han, Maximilian J Hochmair, Ki Hyeong Lee, Angelo Delmonte, Maria Rosario García Campelo, Dong-Wan Kim, Frank Griesinger, Enriqueta Felip, Raffaele Califano, Alexander Spira, Scott N Gettinger, Marcello Tiseo, Huamao M Lin, Neeraj Gupta, Michael J Hanley, Quanhong Ni, Pingkuan Zhang, Sanjay Popat
Journal: JOURNAL OF CLINICAL ONCOLOGY
Volume: ,
High ImpactMolecular subtypes of oropharyngeal cancer show distinct immune microenvironment related with immune checkpoint blockade response
Min Hwan Kim, Jae-Hwan Kim, Ji Min Lee, Jae Woo Choi, Dongmin Jung, Hojin Cho, Hyundeok Kang, Min Hee Hong, Su Jin Heo, Se Heon Kim, Eun Chang Choi, Da Hee Kim, Young Min Park, Sangwoo Kim, Sun Och Yoon, Yoon Woo Koh, Byoung Chul Cho, Hye Ryun Kim
Journal: BRITISH JOURNAL OF CANCER
Volume: ,
Medium ImpactMouse-human co-clinical trials demonstrate superior anti-tumour effects of buparlisib (BKM120) and cetuximab combination in squamous cell carcinoma of head and neck
Hye Ryun Kim, Han Na Kang, Mi Ran Yun, Kwon Young Ju, Jae Woo Choi, Dong Min Jung, Kyoung Ho Pyo, Min Hee Hong, Myoung-Ju Ahn, Jong-Mu Sun, Han Sang Kim, Jinna Kim, Jinseon Yoo, Kyu Ryung Kim, Yoon Woo Koh, Se Heon Kim, Eun Chang Choi, Sun Ock Yoon, Hyo Sup Shim, Soonmyung Paik, Tae-Min Kim, Byoung Chul Cho
Journal: BRITISH JOURNAL OF CANCER
Volume: ,
Medium ImpactHyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18-12
Yiyue Huang, Yuexiang Su, Yuanyuan Chen, Jingxuan Xu, Lu Zhu, Haowen Wei, Shuiling Qin, Yuchong Peng, Lunan Qi
Journal: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Volume: ,
Low ImpactSingle-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer
Kim K, Park S, Park SY, Kim G, Park SM, Cho JW, Kim DH, Park YM, Koh YW, Kim HR, Ha SJ
Journal: GENOME MEDICINE
Volume: ,
High ImpactPeripheral natural killer cells and myeloid-derived suppressor cells correlate with anti-PD-1 responses in non-small cell lung cancer
Je-In Youn, Su-Myeong Park, Seyeon Park, Gamin Kim, Hee-Jae Lee, Jimin Son, Min Hee Hong, Aziz Ghaderpour, Bumseo Baik, Jahirul Islam, Ji-Woong Choi, Eun-Young Lee, Hang-Rae Kim, Sang-Uk Seo, Soonmyung Paik, Hong In Yoon, Inkyung Jung, Chun-Feng Xin, Hyun-Tak Jin, Byoung Chul Cho, Seung-Yong Seong, Sang-Jun Ha, Hye Ryun Kim
Journal: SCIENTIFIC REPORTS
Volume: ,
Medium ImpactImmunotherapy for Non-small Cell Lung Cancer: Current Landscape and Future Perspectives
Diamone Gathers, Cameron Oswalt, Laura Alder, Kevin Chen, Jordyn P Higgins, Jeffrey M Clarke, Eziafa I Oduah
Journal: IMMUNE NETWORK
Volume: ,
Medium ImpactEstablishment and characterization of patient-derived xenografts as paraclinical models for head and neck cancer
Han Na Kang, Jae-Hwan Kim, A-Young Park, Jae Woo Choi, Sun Min Lim, Jinna Kim, Eun Joo Shin, Min Hee Hong, Kyoung-Ho Pyo, Mi Ran Yun, Dong Hwi Kim, Hanna Lee, Sun Och Yoon, Da Hee Kim, Young Min Park, Hyung Kwon Byeon, Inkyung Jung, Soonmyung Paik, Yoon Woo Koh, Byoung Chul Cho, Hye Ryun Kim
Journal: BMC CANCER
Volume: ,
Low ImpactThe Interplay between Slow-Cycling, Chemoresistant Cancer Cells and Fibroblasts Creates a Proinflammatory Niche for Tumor Progression
Jaebeom Cho, Hyo-Jong Lee, Su Jung Hwang, Hye-Young Min, Han Na Kang, A-Young Park, Seung Yeob Hyun, Jeong Yeon Sim, Ho Jin Lee, Hyun-Ji Jang, Young-Ah Suh, Sungyoul Hong, Young Kee Shin, Hye Ryun Kim, Ho-Young Lee
Journal: CANCER RESEARCH
Volume: ,
High ImpactMAML1/2 promote YAP/TAZ nuclear localization and tumorigenesis
Jiyoung Kim, Hyeryun Kwon, You Keun Shin, Gahyeon Song, Taebok Lee, Youngeun Kim, Wonyoung Jeong, Ukjin Lee, Xianglan Zhang, Gilyeong Nam, Hei-Cheul Jeung, Wantae Kim, Eek-Hoon Jho
Journal: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume: ,
High ImpactRepotrectinib Exhibits Potent Antitumor Activity in Treatment-Naïve and Solvent-Front-Mutant ROS1-Rearranged Non-Small Cell Lung Cancer
Mi Ran Yun, Dong Hwi Kim, Seok-Young Kim, Hyeong-Seok Joo, You Won Lee, Hun Mi Choi, Chae Won Park, Seong Gu Heo, Han Na Kang, Sung Sook Lee, Adam J Schoenfeld, Alexander Drilon, Seok-Gu Kang, Hyo Sup Shim, Min Hee Hong, J Jean Cui, Hye Ryun Kim, Byoung Chul Cho
Journal: CLINICAL CANCER RESEARCH
Volume: ,
High ImpactPrognostic Value of CD200R1 mRNA Expression in Head and Neck Squamous Cell Carcinoma
Hyun Chang, Yun-Gyoo Lee, Yoon Ho Ko, Jang Ho Cho, Jong-Kwon Choi, Keon Uk Park, Eun Joo Kang, Keun-Wook Lee, Sun Min Lim, Jin-Soo Kim, Hyun Woo Lee, Min Kyoung Kim, In Gyu Hwang, Sangwoo Kim, Byung-Ho Nam, Hye Ryun Kim
Journal: CANCERS
Volume: ,
Medium ImpactCombination of PD-L1 and PVR determines sensitivity to PD-1 blockade
Bo Ryeong Lee, Sehyun Chae, Jihyun Moon, Myeong Joon Kim, Hankyu Lee, Hyuk Wan Ko, Byoung Chul Cho, Hyo Sup Shim, Daehee Hwang, Hye Ryun Kim, Sang-Jun Ha
Journal: JCI INSIGHT
Volume: ,
Medium ImpactPembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study
Fumihiro Nishimura, Kentaro Oniki, Atsuhiro Yamashita, Keiichi Honda, Kenji Kawata, Tomoko Ushijima, Shinsuke Hamada, Shigeyuki Miyamura, Junji Saruwatari
Journal: JOURNAL OF CLINICAL ONCOLOGY
Volume: ,
High ImpactComprehensive analyses of immunodynamics and immunoreactivity in response to treatment in ALK-positive non-small-cell lung cancer
Kyoung-Ho Pyo, Sun Min Lim, Chae-Won Park, Ha-Ni Jo, Jae Hwan Kim, Mi-Ran Yun, Dohee Kim, Chun-Feng Xin, Wongeun Lee, Bianca Gheorghiu, Min Hee Hong, Hye Ryun Kim, Hyo Sup Shim, Mi Jang, Sung Sook Lee, Byoung Chul Cho
Journal: JOURNAL FOR IMMUNOTHERAPY OF CANCER
Volume: ,
High ImpactAntitumor Activity of Amivantamab (JNJ-61186372), an EGFR-MET Bispecific Antibody, in Diverse Models of EGFR Exon 20 Insertion-Driven NSCLC
Jiyeon Yun, Soo-Hwan Lee, Seok-Young Kim, Seo-Yoon Jeong, Jae-Hwan Kim, Kyoung-Ho Pyo, Chae-Won Park, Seong Gu Heo, Mi Ran Yun, Sangbin Lim, Sun Min Lim, Min Hee Hong, Hye Ryun Kim, Meena Thayu, Joshua C Curtin, Roland E Knoblauch, Matthew V Lorenzi, Amy Roshak, Byoung Chul Cho
Journal: CANCER DISCOVERY
Volume: ,
High ImpactTreatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13-01)
Eun Joo Kang, Yun-Gyoo Lee, Bhumsuk Keam, Jin-Hyuk Choi, Jin-Soo Kim, Keon Uk Park, Kyoung Eun Lee, Hyo Jung Kim, Keun-Wook Lee, Min Kyoung Kim, Hee Kyung Ahn, Seong Hoon Shin, Jii Bum Lee, Jung Hye Kwon, Hye Ryun Kim, Sung-Bae Kim, Hwan Jung Yun
Journal: BMC CANCER
Volume: ,
Low ImpactGenome-wide identification of differentially methylated promoters and enhancers associated with response to anti-PD-1 therapy in non-small cell lung cancer
Jae-Won Cho, Min Hee Hong, Sang-Jun Ha, Young-Joon Kim, Byoung Chul Cho, Insuk Lee, Hye Ryun Kim
Journal: EXPERIMENTAL AND MOLECULAR MEDICINE
Volume: ,
High Impact2019
21 publicationsHigh CD3 and ICOS and low TIM-3 expression predict favourable survival in resected oesophageal squamous cell carcinoma
Min Hee Hong, Su-Jin Shin, Sung Kwan Shin, Dae Joon Kim, Jae Ill Zo, Young Mog Shim, Seung Eun Lee, Byoung Chul Cho, Seong Yong Park, Yoon-La Choi, Hye Ryun Kim
Journal: SCIENTIFIC REPORTS
Volume: ,
Medium ImpactTumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive function
Hye Ryun Kim, Hyo Jin Park, Jimin Son, Jin Gu Lee, Kyung Young Chung, Nam Hoon Cho, Hyo Sup Shim, Seyeon Park, Gamin Kim, Hong In Yoon, Hyun Gyung Kim, Yong Woo Jung, Byoung Chul Cho, Seong Yong Park, Sun Young Rha, Sang-Jun Ha
Journal: JOURNAL FOR IMMUNOTHERAPY OF CANCER
Volume: ,
High ImpactDynamic changes in PD-L1 expression and CD8+ T cell infiltration in non-small cell lung cancer following chemoradiation therapy
Eun-Ah Choe, Yoon Jin Cha, Jae-Hwan Kim, Kyoung Ho Pyo, Min Hee Hong, Seong Yong Park, Hyo Sup Shim, Inkyung Jung, Chang Young Lee, Byoung Chul Cho, Hye Ryun Kim
Journal: LUNG CANCER
Volume: ,
Medium ImpactHyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancer
Qingwang Hua, Zhenyun Ye, Suyue Liu
Journal: Annals of Oncology
Volume: ,
High ImpactPredictive factors for the development of diabetes in cancer patients treated with phosphatidylinositol 3-kinase inhibitors
Gyuri Kim, Myungeun Yoo, Min Hee Hong, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Hye Ryun Kim, Yong-Ho Lee, Byoung Chul Cho
Journal: Cancer Chemotherapy and Pharmacology
Volume: ,
Low ImpactA phase Ib study of the combination of afatinib and ruxolitinib in EGFR mutant NSCLC with progression on EGFR-TKIs
Ji Soo Park, Min Hee Hong, You Jin Chun, Hye Ryun Kim, Byoung Chul Cho
Journal: Lung Cancer
Volume: ,
Medium ImpactInvestigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma
Sun Min Lim, Sang Hee Cho, In Gyu Hwang, Jae Woo Choi, Hyun Chang, Myung-Ju Ahn, Keon Uk Park, Ji-Won Kim, Yoon Ho Ko, Hee Kyung Ahn, Byoung Chul Cho, Byung-Ho Nam, Sang Hoon Chun, Ji Hyung Hong, Jung Hye Kwon, Jong Gwon Choi, Eun Joo Kang, Tak Yun, Keun-Wook Lee, Joo-Hang Kim, Jin Soo Kim, Hyun Woo Lee, Min Kyoung Kim, Dongmin Jung, Ji Eun Kim, Bhumsuk Keam, Hwan Jung Yun, Sangwoo Kim, Hye Ryun Kim
Journal: Cancer Research and Treatment
Volume: ,
Medium ImpactA Randomized, Open-Label, Phase II Study Comparing Pemetrexed Plus Cisplatin Followed by Maintenance Pemetrexed versus Pemetrexed Alone in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Non-small Cell Lung Cancer after Failure of First-Line EGFR Tyrosine Kinase Inhibitor: KCSG-LU12-13
Kwai Han Yoo, Su Jin Lee, Jinhyun Cho, Ki Hyeong Lee, Keon Uk Park, Ki Hwan Kim, Eun Kyung Cho, Yoon Hee Choi, Hye Ryun Kim, Hoon-Gu Kim, Heui June Ahn, Ha Yeon Lee, Hwan Jung Yun, Jin-Hyoung Kang, Jaeheon Jeong, Moon Young Choi, Sin-Ho Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn
Journal: CANCER RESEARCH AND TREATMENT
Volume: ,
Medium ImpactComprehensive analysis of the characteristics and treatment outcomes of patients with non-small cell lung cancer treated with anti-PD-1 therapy in real-world practice
Beung-Chul Ahn, Kyoung-Ho Pyo, Chun-Feng Xin, Dongmin Jung, Hyo Sup Shim, Chang Young Lee, Seong Yong Park, Hong In Yoon, Min Hee Hong, Byoung Chul Cho, Hye Ryun Kim
Journal: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Volume: ,
Low ImpactYH25448, an Irreversible EGFR-TKI with Potent Intracranial Activity in EGFR Mutant Non-Small Cell Lung Cancer
Jiyeon Yun, Min Hee Hong, Seok-Young Kim, Chae-Won Park, Soyoung Kim, Mi Ran Yun, Han Na Kang, Kyoung-Ho Pyo, Sung Sook Lee, Jong Sung Koh, Ho-Juhn Song, Dong Kyun Kim, Young-Sung Lee, Se-Woong Oh, Soongyu Choi, Hye Ryun Kim, Byoung Chul Cho
Journal: CLINICAL CANCER RESEARCH
Volume: ,
High ImpactTRIUMPH Trial: One Small Step Could Become One Giant Leap for Precision Oncology in Head and Neck Cancer
Bhumsuk Keam, Hye Ryun Kim, Hwan Jung Yun
Journal: CANCER RESEARCH AND TREATMENT
Volume: ,
Medium ImpactIndoor radon exposure increases tumor mutation burden in never-smoker patients with lung adenocarcinoma
Sun Min Lim, Jae Woo Choi, Min Hee Hong, Dongmin Jung, Chang Young Lee, Seong Yong Park, Hyo Sup Shim, Seungsoo Sheen, Kyeong Im Kwak, Dae Ryong Kang, Byoung Chul Cho, Hye Ryun Kim
Journal: LUNG CANCER
Volume: ,
Medium ImpactReal-World Analysis of the Efficacy of Rebiopsy and EGFR Mutation Test of Tissue and Plasma Samples in Drug-Resistant Non-Small Cell Lung Cancer
Min Hee Hong, Hye Ryun Kim, Beung Chul Ahn, Su Jin Heo, Jee Hung Kim, Byoung Chul Cho
Journal: YONSEI MEDICAL JOURNAL
Volume: ,
Low ImpactThe Ratio of Peripheral Regulatory T Cells to Lox-1+ Polymorphonuclear Myeloid-derived Suppressor Cells Predicts the Early Response to Anti-PD-1 Therapy in Patients with Non-Small Cell Lung Cancer
Hye Ryun Kim, Su-Myeong Park, Sang-Uk Seo, Inkyung Jung, Hong In Yoon, Dmitry I Gabrilovich, Byoung Chul Cho, Seung-Yong Seong, Sang-Jun Ha, Je-In Youn
Journal: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Volume: ,
High ImpactNeoadjuvant therapy for thymic neoplasms reduces tumor volume per 3D-reconstructed images but does not improve the complete resection rate
Suh JW, Park SY, Lee CY, Song SH, Kim DJ, Paik HC, Chung KY, Hong MH, Kim HR, Cho BC, Lee JG
Journal: PLOS ONE
Volume: ,
Low ImpactImpact of Treatment-Related Lymphopenia on Immunotherapy for Advanced Non-Small Cell Lung Cancer
Ye Zhang, Cheng Huang, Shanqing Li
Journal: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Volume: ,
Medium ImpactLBA1_PR - Nivolumab (nivo) plus ipilimumab (ipi), nivo, or placebo (pbo) as maintenance therapy in patients (pts) with extensive disease small cell lung cancer (ED-SCLC) after first-line (1L) platinum-based chemotherapy (chemo): Results from the double-blind, randomized phase III CheckMate 451 study
Owonikoko TK, Kim HR, Govindan R, Ready N, Reck M, Peters S, Dakhil SR, Navarro A, Rodriguez-Cid J, Schenker M, Lee JS
Journal: ANNALS OF ONCOLOGY
Volume: ,
High ImpactPatient-Derived Cells to Guide Targeted Therapy for Advanced Lung Adenocarcinoma
Seok-Young Kim, Ji Yeon Lee, Dong Hwi Kim, Hyeong -Seok Joo, Mi Ran Yun, Dongmin Jung, Jiyeon Yun, Seong Gu Heo, Beung -Chul Ahn, Chae Won Park, Kyoung Ho Pyo, You Jin Chun, Min Hee Hong, Hye Ryun Kim, Byoung Chul Cho
Journal: SCIENTIFIC REPORTS
Volume: ,
Medium ImpactMolecular characterization of lung adenocarcinoma from Korean patients using next generation sequencing
You Jin Chun, Jae Woo Choi, Min Hee Hong, Dongmin Jung, Hyeonju Son, Eun Kyung Cho, Young Joo Min, Sang-We Kim, Keunchil Park, Sung Sook Lee, Sangwoo Kim, Hye Ryun Kim, Byoung Chul Cho
Journal: PLOS ONE
Volume: ,
Low ImpactTargeting YAP to overcome acquired resistance to ALK inhibitors in ALK-rearranged lung cancer
Mi Ran Yun, Hun Mi Choi, You Won Lee, Hyeong Seok Joo, Chae Won Park, Jae Woo Choi, Dong Hwi Kim, Han Na Kang, Kyoung-Ho Pyo, Eun Joo Shin, Hyo Sup Shim, Ross A Soo, James Chih-Hsin Yang, Sung Sook Lee, Hyun Chang, Min Hwan Kim, Min Hee Hong, Hye Ryun Kim, Byoung Chul Cho
Journal: EMBO MOLECULAR MEDICINE
Volume: ,
High ImpactLazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1-2 study
Myung-Ju Ahn, Ji-Youn Han, Ki Hyeong Lee, Sang-We Kim, Dong-Wan Kim, Yun-Gyoo Lee, Eun Kyung Cho, Joo-Hang Kim, Gyeong-Won Lee, Jong-Seok Lee, Young Joo Min, Jin-Soo Kim, Sung Sook Lee, Hye Ryun Kim, Min Hee Hong, Jin Seok Ahn, Jong-Mu Sun, Heung Tae Kim, Dae Ho Lee, Sohee Kim, Byoung Chul Cho
Journal: LANCET ONCOLOGY
Volume: ,
High Impact2018
11 publicationsEstablishment of a platform of non-small-cell lung cancer patient-derived xenografts with clinical and genomic annotation
Josiah Voth Park, Raghav Chandra, Ling Cai, Debolina Ganguly, Huiyu Li, Jason E Toombs, Luc Girard, Rolf A Brekken, John D Minna
Journal: LUNG CANCER
Volume: ,
Medium ImpactBrigatinib versus Crizotinib in ALK-Positive Non–Small-Cell Lung Cancer
Vera Damuzzo, Lorenzo Gasperoni, Luna Del Bono, Andrea Ossato, Alessandro Inno, Andrea Messori
Journal: New England Journal of Medicine
Volume: ,
High ImpactERK-dependent IL-6 autocrine signaling mediates adaptive resistance to pan-PI3K inhibitor BKM120 in head and neck squamous cell carcinoma
M R Yun, H M Choi, H N Kang, Yw Lee, H-S Joo, D H Kim, H R Kim, M H Hong, S O Yoon, B C Cho
Journal: ONCOGENE
Volume: ,
Medium ImpactSurvival and Functional Outcome after Treatment for Primary Base of Tongue Cancer: A Comparison of Definitive Chemoradiotherapy versus Surgery Followed by Adjuvant Radiotherapy.
Sangjoon Park, Yeona Cho, Jeongshim Lee, Yoon Woo Koh, Se-Heon Kim, Eun Chang Choi, Hye Ryun Kim, Ki Chang Keum, Kyung Ran Park, Chang Geol Lee
Journal: CANCER RESEARCH AND TREATMENT
Volume: ,
Medium ImpactCharacteristics and Outcome of ROS1-Positive Non-Small Cell Lung Cancer Patients in Routine Clinical Practice
Sehhoon Park, Beung-Chul Ahn, Sung Won Lim, Jong-Mu Sun, Hye Ryun Kim, Min Hee Hong, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park, Yoon La Choi, Byoung Chul Cho, Myung-Ju Ahn
Journal: JOURNAL OF THORACIC ONCOLOGY
Volume: ,
High ImpactEnhancer Remodeling and MicroRNA Alterations Are Associated with Acquired Resistance to ALK Inhibitors.
Mi Ran Yun, Sun Min Lim, Seon-Kyu Kim, Hun Mi Choi, Kyoung-Ho Pyo, Seong Keun Kim, Ji Min Lee, You Won Lee, Jae Woo Choi, Hye Ryun Kim, Min Hee Hong, Keeok Haam, Nanhyung Huh, Jong-Hwan Kim, Yong Sung Kim, Hyo Sup Shim, Ross Andrew Soo, Jin-Yuan Shih, James Chih-Hsin Yang, Mirang Kim, Byoung Chul Cho
Journal: CANCER RESEARCH
Volume: ,
High ImpactRadon Exposure-induced Genetic Variations in Lung Cancers among Never Smokers
Jung Ran Choi, Sang Baek Koh, Hye Ryun Kim, Hyojin Lee, Dae Ryong Kang
Journal: JOURNAL OF KOREAN MEDICAL SCIENCE
Volume: ,
Low ImpactEffects of Serum Albumin, Calcium Levels, Cancer Stage and Performance Status on Weight Loss in Parathyroid Hormone-Related Peptide Positive or Negative Patients with Cancer
Walker Lyons, E McAuley Fish, Richard J Bleicher, Cecilia Chang, Allison A Aggon, Alycia L So, Andrea S Porpiglia, Austin D Williams
Journal: Endocrinology and Metabolism (대한내분비학회지)
Volume: ,
Low ImpactA Clinical Trial of Combination Neoadjuvant Chemotherapy and Transoral Robotic Surgery in Patients with T3 and T4 Laryngo-Hypopharyngeal Cancer
Young Min Park, Ki Chang Keum, Hye Ryun Kim, Byoung Chul Cho, Da Hee Kim, Nam Hoon Cho, Se-Heon Kim
Journal: ANNALS OF SURGICAL ONCOLOGY
Volume: ,
Medium ImpactThe Benefit of Pro Re Nata Antiemetics Provided With Guideline-Consistent Antiemetics in Delayed Nausea Control
Sun Young Rha, Joohyuk Sohn, Gun Min Kim, Hye Ryun Kim, Jiyeon Lee
Journal: CANCER NURSING
Volume: ,
Low ImpactEfficacy and safety of vinorelbine plus cisplatin chemotherapy for patients with recurrent and/or metastatic salivary gland cancer of the head and neck
Marta Rogalska, Pawel Scierski, Marta Gamrot-Wrzol, Maciej Misiolek, Wojciech Scierski
Journal: HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
Volume: ,
Low Impact2017
19 publicationsCo-clinical trials demonstrate predictive biomarkers for dovitinib, an FGFR inhibitor, in lung squamous cell carcinoma
H R Kim, H N Kang, H S Shim, E Y Kim, J Kim, D J Kim, J G Lee, C Y Lee, M H Hong, S-M Kim, H Kim, K-H Pyo, M R Yun, H J Park, J Y Han, H A Youn, M-J Ahn, S Paik, T-M Kim, B C Cho
Journal: ANNALS OF ONCOLOGY
Volume: ,
High ImpactPrevalence and prognostic implications of psychological distress in patients with gastric cancer
Gun Min Kim, Seung Jun Kim, Su Kyung Song, Hye Ryun Kim, Beo Deul Kang, Sung Hoon Noh, Hyun Cheol Chung, Kyung Ran Kim, Sun Young Rha
Journal: BMC CANCER
Volume: ,
Low ImpactOptimal dose and volume for postoperative radiotherapy in brain oligometastases from lung cancer: a retrospective study
Seung Yeun Chung, Jong Hee Chang, Hye Ryun Kim, Byoung Chul Cho, Chang Geol Lee, Chang-Ok Suh
Journal: RADIATION ONCOLOGY JOURNAL
Volume: ,
Low ImpactOpen-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 Rearrangement.
Sun Min Lim, Hye Ryun Kim, Jong-Seok Lee, Ki Hyeong Lee, Yun-Gyoo Lee, Young Joo Min, Eun Kyung Cho, Sung Sook Lee, Bong-Seog Kim, Moon Young Choi, Hyo Sup Shim, Jin-Haeng Chung, Yoon La Choi, Min Jeong Lee, Maria Kim, Joo-Hang Kim, Siraj M Ali, Myung-Ju Ahn, Byoung Chul Cho
Journal: JOURNAL OF CLINICAL ONCOLOGY
Volume: ,
High ImpactDetection of activating and acquired resistant mutation in plasma from EGFR-mutated NSCLC patients by peptide nucleic acid (PNA) clamping-assisted fluorescence melting curve analysis
Chang Gon Kim, Hyo Sup Shim, Min Hee Hong, Yoon Jin Cha, Su Jin Heo, Hyung Soon Park, Jee Hung Kim, Jin Gu Lee, Chang Young Lee, Byoung Chul Cho, Hye Ryun Kim
Journal: ONCOTARGET
Volume: ,
Low ImpactEstablishment of a Conditional Transgenic Mouse Model Recapitulating EML4-ALK-Positive Human Non-Small Cell Lung Cancer
Kyoung Ho Pyo, Sun Min Lim, Hye Ryun Kim, Young Hoon Sung, Mi Ran Yun, Sung-Moo Kim, Hwan Kim, Han Na Kang, Ji Min Lee, Sang Gyun Kim, Chae Won Park, Hyun Chang, Hyo Sup Shim, Han-Woong Lee, Byoung Chul Cho
Journal: JOURNAL OF THORACIC ONCOLOGY
Volume: ,
High ImpactOsimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer
Mok TS, Wu Y-L, Ahn M-J, Garassino MC, Kim HR, Ramalingam SS, Shepherd FA, He Y, Akamatsu H, Theelen WS, Lee CK, Sebastian M, Templeton A, Mann H, Marotti M, Ghiorghiu S, Papadimitrakopoulou VA; AURA3 Investigators
Journal: NEW ENGLAND JOURNAL OF MEDICINE
Volume: ,
High ImpactPatient Experience of Symptoms and Side Effects when Treated with Osimertinib for Advanced Non-Small-Cell Lung Cancer: A Qualitative Interview Substudy
Rydén A, Blackhall F, Kim HR, Pillai RN, Braam L, Martin ML, Walding A
Journal: PATIENT-PATIENT CENTERED OUTCOMES RESEARCH
Volume: ,
Low ImpactNovel Genetic Associations Between Lung Cancer and Indoor Radon Exposure
Jung Ran Choi, Sang-Baek Koh, Seong Yong Park, Hye Ryun Kim, Hyojin Lee, Dae Ryong Kang
Journal: JOURNAL OF CANCER PREVENTION
Volume: ,
Low ImpactConcordance of programmed death-ligand 1 expression between primary and metastatic non-small cell lung cancer by immunohistochemistry and RNA in situ hybridization
Hye Ryun Kim, Yoon Jin Cha, Min Hee Hong, Manoj Gandhi, Shauna Levinson, Inkyung Jung, Jin Gu Lee, Chang Young Lee, Byoung Chul Cho, Sang-Jun Ha, Hyo Sup Shim
Journal: ONCOTARGET
Volume: ,
Low ImpactTransoral robotic surgery-based therapy in patients with stage III-IV oropharyngeal squamous cell carcinoma
Young Min Park, Hye Ryun Kim, Byoung Chul Cho, Ki Chang Keum, Nam Hoon Cho, Se-Heon Kim
Journal: ORAL ONCOLOGY
Volume: ,
Medium ImpactArchitectural patterns of p16 immunohistochemical expression associated with cancer immunity and prognosis of head and neck squamous cell carcinoma
Hyang Joo Ryu, Eun Kyung Kim, Su Jin Heo, Byoung Chul Cho, Hye Ryun Kim, Sun Och Yoon
Journal: APMIS
Volume: ,
Low ImpactNext-generation sequencing reveals novel resistance mechanisms and molecular heterogeneity in EGFR-mutant non-small cell lung cancer with acquired resistance to EGFR-TKIs
Choong-Kun Lee, Sora Kim, Jae Seok Lee, Jeong Eun Lee, Sung-Moo Kim, In Seok Yang, Hye Ryun Kim, Jeong Ho Lee, Sangwoo Kim, Byoung Chul Cho
Journal: LUNG CANCER
Volume: ,
Medium ImpactValidation of ALK/ROS1 Dual Break Apart FISH Probe probe in non-small-cell lung cancer
Federica Zito Marino, Giulio Rossi, Immacolata Cozzolino, Marco Montella, Mariacarolina Micheli, Giuseppe Bogina, Enrico Munari, Matteo Brunelli, Renato Franco
Journal: LUNG CANCER
Volume: ,
Medium ImpactActivity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study
Ahn MJ, Kim DW, Cho BC, Kim SW, Lee JS, Ahn JS, Kim TM, Lin CC, Kim HR, John T, Kao S, Goldman JW, Su WC, Natale R, Rabbie S, Harrop B, Overend P, Yang Z, Yang JC
Journal: LANCET RESPIRATORY MEDICINE
Volume: ,
High ImpactA randomized; phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01) (vol 8; pg 15943; 2017)
Kim HR, Jang JS, Sun JM, Ahn MJ, Kim DW, Jung I, Lee KH, Kim JH, Lee DH, Kim SW, Cho BC
Journal: ONCOTARGET
Volume: ,
Low ImpactPredictive factors of early distant brain failure after gamma knife radiosurgery alone in patients with brain metastases of non-small-cell lung cancer
Robert H Press, Danielle M Boselli, James T Symanowski, Scott P Lankford, Robert J McCammon, Benjamin J Moeller, John H Heinzerling, Carolina E Fasola, Stuart H Burri, Kirtesh R Patel, Anthony L Asher, Ashley L Sumrall, Walter J Curran, Hui-Kuo G Shu, Ian R Crocker, Roshan S Prabhu
Journal: JOURNAL OF NEURO-ONCOLOGY
Volume: ,
Low ImpactSignificance of immune checkpoint proteins in EGFR-mutant non-small cell lung cancer
Zhidong Yin, Bohao Sun, Lu Cheng, Xi Xu, Sisi Wang, Shumei Wei, Er Jin
Journal: LUNG CANCER
Volume: ,
Medium ImpactClinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01)
Kristina Lindemann, Dominique Berton, Jalid Sehouli, René DePont Christensen, Sevilay Altintas, Anja Ør Knudsen, Pierre-Etienne Heudel, Beyhan Ataseven, Ignace Vergote, Gabriel Lindahl, Coriolan Lebreton, Fabienne Schochter, Annika Auranen, Philippe Follana, Kristine Madsen, Frédéric Selle, Karen Stampe Petersson, Florence Joly, Elena Ioana Braicu, Mansoor Raza Mirza
Journal: CANCER
Volume: ,
High Impact2016
22 publicationsPharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapy
Hyung Soon Park, Sun Min Lim, Ho Jung Shin, Arthur Cho, Jae-Gook Shin, Min Goo Lee, Hye Ryun Kim, Joo Hang Kim, Byoung Chul Cho
Journal: PHARMACOGENETICS AND GENOMICS
Volume: ,
Low ImpactAssessment of Adrenal Function and Health-Related Quality of Life in Advanced Gastric Cancer Patients Who Received First-Line Chemotherapy.
Hye Ryun Kim, Jee Hung Kim, Yumie Rhee, Hosun Lee, Seung Eun Song, Chan Kim, Sukyung Song, Sung Hoon Noh, Sun Young Rha
Journal: ONCOLOGY
Volume: ,
Low ImpactClinical course of stage IV invasive mucinous adenocarcinoma of the lung
Yoon Jin Cha, Hye Ryun Kim, Hye-Jeong Lee, Byoung Chul Cho, Hyo Sup Shim
Journal: LUNG CANCER
Volume: ,
Medium ImpactPD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients
Ximo Xu, Jingyi Liu, Wei Qin, Chengsheng Ding, Zhenghao Cai, Duohuo Shu, Hao Zhong, Yanyan Hu, Mengqin Yu, Leqi Zhou, Jianwen Li, Minhua Zheng, Bin Li, Sen Zhang, Xiao Yang, Bo Feng
Journal: SCIENTIFIC REPORTS
Volume: ,
Medium ImpactClinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants
Yudong Su, Xiang Long, Yang Song, Peng Chen, Shanqing Li, Huaxia Yang, Pancheng Wu, Yanyu Wang, Zhongxing Bing, Zhili Cao, Lei Cao, Yijun Wu, Zhe Zhang, Jing Liu, Bing Li, Jianxing Xiang, Ke Ma, Tengfei Zhang, Lu Zhang, Xinru Mao, Hao Liu, Puyuan Xing, Naixin Liang
Journal: JOURNAL OF TRANSLATIONAL MEDICINE
Volume: ,
Medium ImpactInduction docetaxel and S-1 followed by concomitant radiotherapy with low-dose daily cisplatin in locally advanced head and neck carcinoma
Hye Ryun Kim, Chang Geol Lee, Eun Chang Choi, Joo Hang Kim, Yoon Woo Koh, Byoung Chul Cho
Journal: HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
Volume: ,
Low ImpactLongitudinal monitoring of EGFR mutations in plasma predicts outcomes of NSCLC patients treated with EGFR TKIs: Korean Lung Cancer Consortium (KLCC-12-02)
Ji Yun Lee, Xu Qing, Wei Xiumin, Bai Yali, Sangah Chi, So Hyeon Bak, Ho Yun Lee, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Eun Kyung Cho, Dong-Wan Kim, Hye Ryun Kim, Young Joo Min, Sin-Ho Jung, Keunchil Park, Mao Mao, Myung-Ju Ahn
Journal: ONCOTARGET
Volume: ,
Low ImpactNext-generation sequencing reveals somatic mutations that confer exceptional response to everolimus
Sun Min Lim, Hyung Soon Park, Sangwoo Kim, Sora Kim, Siraj M Ali, Joel R Greenbowe, In Seok Yang, Nak-Jung Kwon, Jae Lyun Lee, Min-Hee Ryu, Jin-Hee Ahn, Jeeyun Lee, Min Goo Lee, Hyo Song Kim, Hyunki Kim, Hye Ryun Kim, Yong Wha Moon, Hyun Cheol Chung, Joo-Hang Kim, Yoon-Koo Kang, Byoung Chul Cho
Journal: ONCOTARGET
Volume: ,
Low ImpactA randomized phase II trial of ERCC1 and RRM1 mRNA expression-based chemotherapy versus docetaxel/carboplatin in advanced non-small cell lung cancer
Su Jin Heo, Inkyung Jung, Choong-Kun Lee, Jee Hung Kim, Sun Min Lim, Yong Wha Moon, Hyo Sup Shim, Jaeheon Jeong, Joo-Hang Kim, Hye Ryun Kim, Byoung Chul Cho
Journal: CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume: ,
Low ImpactER2, a novel human anti-EGFR monoclonal antibody inhibit tumor activity in non-small cell lung cancer models
Han Na Kang, Se-Ho Kim, Mi Ran Yun, Hye Ryun Kim, Sun Min Lim, Min-Soo Kim, Kwang-Won Hong, Sung-Moo Kim, Hwan Kim, Kyoung-Ho Pyo, Hye Ji Park, Joo Yeun Han, Hyun A Youn, Ki-Hwan Chang, Byoung Chul Cho
Journal: LUNG CANCER
Volume: ,
Medium ImpactGenomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative
Sun Min Lim, Eun Young Kim, Hye Ryun Kim, Siraj M Ali, Joel R Greenbowe, Hyo Sup Shim, Hyun Chang, Seungtaek Lim, Soonmyung Paik, Byoung Chul Cho
Journal: ONCOTARGET
Volume: ,
Low ImpactActivation of the Met kinase confers acquired drug resistance in FGFR-targeted lung cancer therapy
S-M Kim, H Kim, M R Yun, H N Kang, K-H Pyo, H J Park, J M Lee, H M Choi, P Ellinghaus, M Ocker, S Paik, H R Kim, B C Cho
Journal: ONCOGENESIS
Volume: ,
Medium ImpactEfficacy and safety of dovitinib in pretreated patients with advanced squamous non-small cell lung cancer with FGFR1 amplification: A single-arm, phase 2 study
Sung Hee Lim, Jong-Mu Sun, Yoon-La Choi, Hye Ryun Kim, Soomin Ahn, Ji Yun Lee, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park, Joo Hang Kim, Byoung Chul Cho, Myung-Ju Ahn
Journal: CANCER
Volume: ,
High ImpactTargeted sequencing identifies genetic alterations that confer primary resistance to EGFR tyrosine kinase inhibitor (Korean Lung Cancer Consortium)
Sun Min Lim, Hye Ryun Kim, Eun Kyung Cho, Young Joo Min, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park, Byoung Chul Cho, Ji-Hyun Lee, Hye Cheol Jeong, Eun Kyung Kim, Joo-Hang Kim
Journal: ONCOTARGET
Volume: ,
Low ImpactPIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma.
Hyo Song Kim, Seung Eun Lee, Yoon Sung Bae, Dae Joon Kim, Chang Geol Lee, Jin Hur, Hyunsoo Chung, Jun Chul Park, Sung Kwan Shin, Sang Kil Lee, Yong Chan Lee, Hye Ryun Kim, Young Mog Shim, Susan S Jewell, Hyunki Kim, Yoon La Choi, Byoung Chul Cho
Journal: ONCOTARGET
Volume: ,
Low ImpactClinicopathological and prognostic significance of programmed cell death ligand-1 expression in lung adenocarcinoma and its relationship with p53 status.
Yoon Jin Cha, Hye Ryun Kim, Chang Young Lee, Byoung Chul Cho, Hyo Sup Shim
Journal: LUNG CANCER
Volume: ,
Medium ImpactA Case of ALK-Rearranged Adenocarcinoma with Small Cell Carcinoma-Like Transformation and Resistance to Crizotinib
Yoon Jin Cha, Byoung Chul Cho, Hye Ryun Kim, Hye-Jeong Lee, Hyo Sup Shim
Journal: JOURNAL OF THORACIC ONCOLOGY
Volume: ,
High ImpactExome sequencing reveals recurrent REV3L mutations in cisplatin-resistant squamous cell carcinoma of head and neck
Kie Kyon Huang, Kang Won Jang, Sangwoo Kim, Han Sang Kim, Sung-Moo Kim, Hyeong Ju Kwon, Hye Ryun Kim, Hwan Jung Yun, Myung Ju Ahn, Keon Uk Park, Kalpana Ramnarayanan, John R McPherson, Shenli Zhang, Je-Keun Rhee, André L Vettore, Kakoli Das, Takatsugu Ishimoto, Joo Hang Kim, Yoon Woo Koh, Se Hun Kim, Eun Chang Choi, Bin Tean Teh, Steven G Rozen, Tae-Min Kim, Patrick Tan, Byoung Chul Cho
Journal: SCIENTIFIC REPORTS
Volume: ,
Medium ImpactSerum PTHrP Predicts Weight Loss in Cancer Patients Independent of Hypercalcemia, Inflammation, and Tumor Burden
Namki Hong, Hye-Jin Yoon, Yong-Ho Lee, Hye Ryun Kim, Byung Wan Lee, Yumie Rhee, Eun Seok Kang, Bong-Soo Cha, Hyun Chul Lee
Journal: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Volume: ,
Medium ImpactHippocampus-Sparing Whole-Brain Radiotherapy and Simultaneous Integrated Boost for Multiple Brain Metastases From Lung Adenocarcinoma: Early Response and Dosimetric Evaluation.
Kyung Hwan Kim, Byoung Chul Cho, Chang Geol Lee, Hye Ryun Kim, Yang Gun Suh, Jun Won Kim, Chihwan Choi, Jong Geal Baek, Jaeho Cho
Journal: TECHNOLOGY IN CANCER RESEARCH & TREATMENT
Volume: ,
Low ImpactPilot Study of a Next-Generation Sequencing-Based Targeted Anticancer Therapy in Refractory Solid Tumors at a Korean Institution
Park HS, Lim SM, Kim S, Kim S, Kim HR, Kwack K, Lee MG, Kim JH, Moon YW
Journal: PLOS ONE
Volume: ,
Low ImpactAlteration status and prognostic value of MET in head and neck squamous cell carcinoma
Cho YA, Kim EK, Heo SJ, Cho BC, Kim HR, Chung JM, Yoon SO
Journal: JOURNAL OF CANCER
Volume: ,
Low Impact2015
10 publicationsResults of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Patients Who Failed First-Line Therapy Containing Dacarbazine
Choong-kun Lee, Minkyu Jung, Hye Jin Choi, Hye Ryun Kim, Hyo Song Kim, Mi Ryung Roh, Joong Bae Ahn, Hyun Cheol Chung, Su Jin Heo, Sun Young Rha, Sang Joon Shin
Journal: CANCER RESEARCH AND TREATMENT
Volume: ,
Medium ImpactAn open label, multicenter, phase II study of dovitinib in advanced thyroid cancer
Sun Min Lim, Woong Youn Chung, Kee-Hyun Nam, Sang-Wook Kang, Jae Yun Lim, Hoon-Gu Kim, Seong Hoon Shin, Jong-Mu Sun, Seong-Geun Kim, Joo-Hang Kim, Chan Woo Kang, Hye Ryun Kim, Byoung Chul Cho
Journal: EUROPEAN JOURNAL OF CANCER
Volume: ,
Medium ImpactThe frequency and impact of FGFR1 amplification on clinical outcomes in Korean patients with small cell lung cancer
Ji Soo Park, Jae-Seok Lee, Eun Young Kim, Ji Ye Jung, Se Kyu Kim, Joon Chang, Dae Joon Kim, Chang Young Lee, Inkyung Jung, Joo Hang Kim, Hye Ryun Kim, Yong Wha Moon, Hyo Song Kim, Byoung Chul Cho, Hyo Sup Shim
Journal: LUNG CANCER
Volume: ,
Medium ImpactFibroblast growth factor receptor 1 gene amplification is associated with poor survival in patients with resected esophageal squamous cell carcinoma.
Dong Wang, Licheng Du, Zhou Wang, Xiangyan Liu, Yejun Qin, Qiangxiu Wang, Zhe Yang, Zhigang Yao, Mo Shi, Bin Shang, Yang Jia, Huaxia Chen, Liang Qiao, Xueqing Wang, Zhaohua Xiao, Zhenchuan Liu
Journal: ONCOTARGET
Volume: ,
Low ImpactPhase II clinical and exploratory biomarker study of dacomitinib in patients with recurrent and/or metastatic squamous cell carcinoma of head and neck
Aldéric M Fraslin, Anne Aupérin, Caroline Even, Jérôme Fayette, Esma Saada-Bouzid, Cédrik Lafond, Lionnel Geoffrois, Jean Bourhis, Joël Guigay, Julia Bonastre
Journal: CLINICAL CANCER RESEARCH
Volume: ,
High ImpactPD-1: Dual guard for immunopathology.
Hye Ryun Kim, Hyo Jin Park, Sang-Jun Ha
Journal: ONCOTARGET
Volume: ,
Low ImpactPhase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma
Fei Yan, Jingni Zhu, Qibing Wu, Yuanyuan Ren, Xinnian Yu, Zijian Sun, Yang Liu, Changjiang Sun, Yan Sun
Journal: ONCOTARGET
Volume: ,
Low ImpactAntitumor Activity and Acquired Resistance Mechanism of Dovitinib (TKI258) in RET-Rearranged Lung Adenocarcinoma
Chan Woo Kang, Kang Won Jang, Jinyoung Sohn, Sung-Moo Kim, Kyoung-Ho Pyo, Hwan Kim, Mi Ran Yun, Han Na Kang, Hye Ryun Kim, Sun Min Lim, Yong Wha Moon, Soonmyung Paik, Dae Joon Kim, Joo Hang Kim, Byoung Chul Cho
Journal: MOLECULAR CANCER THERAPEUTICS
Volume: ,
Medium ImpactThe Clinicopathologic Features and Prognostic Impact of ALK Positivity in Patients with Resected Gastric Cancer
Hong Jae Chon, Hye Ryun Kim, Eunah Shin, Chan Kim, Su Jin Heo, Choong-Kun Lee, Jin Kyu Park, Sung Hoon Noh, Hyun Cheol Chung, Sun Young Rha
Journal: ANNALS OF SURGICAL ONCOLOGY
Volume: ,
Medium ImpactReduced expression of EI24 confers resistance to gefitinib through IGF-1R signaling in PC9 NSCLC cells
Jung-Min Choi, Ji-Young Jang, Yu-Ra Choi, Hye Ryun Kim, Byoung Chul Cho, Han-Woong Lee
Journal: LUNG CANCER
Volume: ,
Medium Impact2014
7 publicationsScreening of ROS1 rearrangements in lung adenocarcinoma by immunohistochemistry and comparison with ALK rearrangements
Diane Frankel, Isabelle Nanni, L'Houcine Ouafik, Clara Camilla, Eric Pellegrino, Nathalie Beaufils, Laurent Greillier, Hervé Dutau, Philippe Astoul, Elise Kaspi, Patrice Roll
Journal: PLOS ONE
Volume: ,
Low ImpactImpact of cigarette smoking on response to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors in lung adenocarcinoma with activating EGFR mutations
Yoon Ki Cha, Ho Yun Lee, Myung-Ju Ahn, Keunchil Park, Jin Seok Ahn, Jong-Mu Sun, Yoon-La Choi, Kyung Soo Lee
Journal: LUNG CANCER
Volume: ,
Medium ImpactClinical and prognostic implications of ALK and ROS1 rearrangements in never-smokers with surgically resected lung adenocarcinoma
Yan Jin, Ping-Li Sun, Hyojin Kim, Eunhyang Park, Hyo Sup Shim, Sanghoon Jheon, Kwhanmien Kim, Choon-Taek Lee, Jin-Haeng Chung
Journal: LUNG CANCER
Volume: ,
Medium ImpactA prospective phase II trial of s-1 and cisplatin-based chemoradiotherapy for locoregionally advanced esophageal cancer
Hyun Chang, Sung Kwan Shin, Byoung Chul Cho, Chang-Geol Lee, Choong Bai Kim, Dae Joon Kim, Jin Gu Lee, Jin Hur, Chang Young Lee, Mi Kyung Bae, Hye Ryun Kim, Sang Kil Lee, Jun Chul Park, Hyuk Lee, Hyoung-Il Kim, Hyunsoo Chung, Jihye Cha, Yong Chan Lee, Joo-Hang Kim
Journal: CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume: ,
Low ImpactPrediction for response duration to epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR mutated never smoker lung adenocarcinoma
Hye Ryun Kim, Byoung Chul Cho, Hyo Sup Shim, Sun Min Lim, Se Kyu Kim, Joon Chang, Dae Joon Kim, Joo Hang Kim
Journal: LUNG CANCER
Volume: ,
Medium ImpactEfficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with renal insufficiency
Melissa Bersanelli, Francesco Facchinetti, Marcello Tiseo, Mariarosa Maiorana, Sebastiano Buti
Journal: EUROPEAN JOURNAL OF CANCER
Volume: ,
Medium ImpactIdentification of somatic mutations in EGFR/KRAS/ALK-negative lung adenocarcinoma in never-smokers
Jin Woo Ahn, Han Sang Kim, Jung-Ki Yoon, Hoon Jang, Soo Min Han, Sungho Eun, Hyo Sup Shim, Hyun-Jung Kim, Dae Joon Kim, Jin Gu Lee, Chang Young Lee, Mi Kyung Bae, Kyung Young Chung, Ji Ye Jung, Eun Young Kim, Se Kyu Kim, Joon Chang, Hye Ryun Kim, Joo Hang Kim, Min Goo Lee, Byoung Chul Cho, Ji Hyun Lee, Duhee Bang
Journal: GENOME MEDICINE
Volume: ,
High Impact2013
9 publicationsThe Impact of Cigarette Smoking on the Frequency of and Qualitative Differences in KRAS Mutations in Korean Patients with Lung Adenocarcinoma
Hye Ryun Kim, Jung Ryun Ahn, Jin Gu Lee, Doo Hee Bang, Sang-Jun Ha, Yun Kyoung Hong, Sun Mi Kim, Ki Chang Nam, Sun Young Rha, Ross A Soo, Gregory J Riely, Joo Hang Kim, Byoung Chul Cho
Journal: YONSEI MEDICAL JOURNAL
Volume: ,
Low ImpactRole of FGF receptors as an emerging therapeutic target in lung squamous cell carcinoma
Lim SM, Kim HR, Shim HS, Soo RA, Cho BC
Journal: FUTURE ONCOLOGY
Volume: ,
Medium ImpactEGFR and TTF-1 Gene Amplification in Surgically Resected Lung Adenocarcinomas: Clinicopathologic Significance and Effect on Response to EGFR-Tyrosine Kinase Inhibitors in Recurred Cases
Jae Seok Lee, Hye Ryun Kim, Chang Young Lee, Mihwa Shin, Hyo Sup Shim
Journal: ANNALS OF SURGICAL ONCOLOGY
Volume: ,
Medium ImpactA phase I trial of gefitinib and nimotuzumab in patients with advanced non-small cell lung cancer (NSCLC)
Se Hyun Kim, Hyo Sup Shim, Jaeho Cho, Jae Heon Jeong, Sun Mi Kim, Yun Kyoung Hong, Ji Hee Sung, Sang-Jun Ha, Hye Ryun Kim, Hyun Chang, Joo Hang Kim, Crombet Tania, Byoung Chul Cho
Journal: LUNG CANCER
Volume: ,
Medium ImpactFibroblast Growth Factor Receptor 1 Gene Amplification Is Associated With Poor Survival and Cigarette Smoking Dosage in Patients With Resected Squamous Cell Lung Cancer
Hye Ryun Kim, Dae Joon Kim, Dae Ryong Kang, Jin Gu Lee, Sun Min Lim, Chang Young Lee, Sun Young Rha, Mi Kyung Bae, Young Joo Lee, Se Hoon Kim, Sang-Jun Ha, Ross Andrew Soo, Kyung Young Chung, Joo Hang Kim, Ji Hyun Lee, Hyo Sup Shim, Byoung Chul Cho
Journal: JOURNAL OF CLINICAL ONCOLOGY
Volume: ,
High ImpactPharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patients
Hye Ryun Kim, Hyung Soon Park, Woo Sun Kwon, Ji Hyun Lee, Yusuke Tanigawara, Sun Min Lim, Hyo Song Kim, Sang Jun Shin, Jung Bae Ahn, Sun Young Rha
Journal: CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume: ,
Low ImpactThe frequency and impact of ROS1 rearrangement on clinical outcomes in never smokers with lung adenocarcinoma
Dara L Aisner, Lynette M Sholl, Lynne D Berry, Michael R Rossi, Heidi Chen, Junya Fujimoto, Andre L Moreira, Suresh S Ramalingam, Liza C Villaruz, Gregory A Otterson, Eric Haura, Katerina Politi, Bonnie Glisson, Jeremy Cetnar, Edward B Garon, Joan Schiller, Saiama N Waqar, Lecia V Sequist, Julie Brahmer, Yu Shyr, Kelly Kugler, Ignacio I Wistuba, Bruce E Johnson, John D Minna, Mark G Kris, Paul A Bunn, David J Kwiatkowski
Journal: ANNALS OF ONCOLOGY
Volume: ,
High ImpactMulticentre phase II trial of bevacizumab combined with docetaxel–carboplatin for the neoadjuvant treatment of triple-negative breast cancer (KCSG BR-0905)
H R Kim, K H Jung, S-A Im, Y-H Im, S Y Kang, K H Park, S Lee, S-B Kim, K-H Lee, J S Ahn, S I Kim, J H Sohn
Journal: ANNALS OF ONCOLOGY
Volume: ,
High ImpactPhase II study of camtobell inj. (belotecan) in combination with cisplatin in patients with previously untreated, extensive stage small cell lung cancer
Seungtaek Lim, Byoung Chul Cho, Ji Ye Jung, Gun Min Kim, Se Hyun Kim, Hye Ryun Kim, Han Sang Kim, Sun Min Lim, Ji Soo Park, Jun Ho Lee, Darae Kim, Eun Young Kim, Moo Suk Park, Young Sam Kim, Se Kyu Kim, Joon Chang, Joo Hang Kim
Journal: LUNG CANCER
Volume: ,
Medium Impact2012
5 publicationsDistinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement
Tomohiro Yoshinari, Takeyuki Nagashima, Hiroki Ishioka, Kohei Inamura, Yoshihiro Nishizono, Mamoru Tasaki, Kanako Iguchi, Atsushi Suzuki, Chikako Sato, Ayako Nakayama, Yasushi Amano, Yukihiro Tateishi, Yosuke Yamanaka, Fumio Osaki, Masayasu Yoshino, Kazuyuki Kuramoto, Tomoyoshi Imaizumi, Masahiko Hayakawa
Journal: CANCER
Volume: ,
High ImpactPhase II study of cisplatin with irinotecan as induction chemotherapy followed by chemoradiotherapy for unresectable stage III non-small cell lung cancer
Hyun Chang, Se Hyun Kim, Byoung Chul Cho, Sang Hyun Yoon, Hye Ryun Kim, Chang Geol Lee, Joo Hang Kim
Journal: ANTICANCER RESEARCH
Volume: ,
Low ImpactThe efficacy and toxicity of S-1 and cisplatin as first-line chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma
Kim HS, Kim HR, Kim GM, Kim HS, Koh YW, Kim SH, Choi EC, Hong YK, Sung JH, Kim SM, Kim JH, Cho BC
Journal: CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume: ,
Low ImpactA Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy
Sang Joon Shin, Joong Bae Ahn, Kyung Soo Park, Yoon Jung Lee, Yong Sang Hong, Tae Won Kim, Hye Ryun Kim, Sun Young Rha, Jae Kyung Roh, Dal-Hyun Kim, Chin Kim, Hyun Cheol Chung
Journal: INVESTIGATIONAL NEW DRUGS
Volume: ,
Low ImpactA phase I pharmacokinetic study of TSU-68 (a multiple tyrosine kinase inhibitor of VEGFR-2, FGF and PDFG) in combination with S-1 and oxaliplatin in metastatic colorectal cancer patients previously treated with chemotherapy
Sang Joon Shin, Minkyu Jung, Hei-Cheul Jeung, Hye Ryun Kim, Sun Young Rha, Jae Kyung Roh, Hyun Cheol Chung, Joong Bae Ahn
Journal: INVESTIGATIONAL NEW DRUGS
Volume: ,
Low Impact2011
2 publicationsEfficacy of oxaliplatin-based chemotherapy in curatively resected colorectal cancer with liver metastasis
Nicholas A Bosma, Alysha R Keehn, Richard Lee-Ying, Safiya Karim, Anthony R MacLean, Darren R Brenner
Journal: ONCOLOGY
Volume: ,
Low ImpactTreatment of recurrent hepatocellular carcinoma after liver transplantation
Wei-Chen Lee, Chih-Hsien Cheng, Tsung-Han Wu, Yu-Chao Wang, Jin-Chiao Lee, Hao-Chien Hung, Chen-Fang Lee, Ting-Jung Wu, Hong-Shiue Chou, Kun-Ming Chan
Journal: ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
Volume: ,
Low Impact2010
1 publicationEfficacy and feasibility of radiofrequency ablation for liver metastases from gastric adenocarcinoma
Jiyang Li, Hongqing Xi, Jianxin Cui, Kecheng Zhang, Yunhe Gao, Wenquan Liang, Aizhen Cai, Bo Wei, Lin Chen
Journal: INTERNATIONAL JOURNAL OF HYPERTHERMIA
Volume: ,
Low Impact2009
5 publicationsClinical features and treatment outcomes of advanced stage primary hepatic angiosarcoma
H R Kim, S Y Rha, S H Cheon, J K Roh, Y N Park, N C Yoo
Journal: ANNALS OF ONCOLOGY
Volume: ,
High ImpactTension pneumopericardium after removal of pericardiocentesis drainage catheter
Hye Ryun Kim, Donghoon Choi, Joo Won Chung, Young Nam Youn, Chi Young Shim
Journal: CARDIOLOGY JOURNAL
Volume: ,
Low ImpactDocetaxel versus paclitaxel combined with 5-FU and leucovorin in advanced gastric cancer: combined analysis of two phase II trials.
Hong Jae Chon, Sun Young Rha, Chong Kun Im, Chan Kim, Min Hee Hong, Hye Ryun Kim, Jung Ryun An, Sung Hoon Noh, Hyun Cheol Chung, Hei-Cheul Jeung
Journal: CANCER RESEARCH AND TREATMENT
Volume: ,
Medium ImpactClinical value of ezrin expression in primary osteosarcoma
Iwona Lugowska, Ewa Mierzejewska, Malgorzata Lenarcik, Teresa Klepacka, Irena Koch, Elzbieta Michalak, Katarzyna Szamotulska
Journal: CANCER RESEARCH AND TREATMENT
Volume: ,
Medium ImpactPrognosis of pN3 stage gastric cancer
Guangmin Wan, Quan Wang, Lu Yang, Gang Xu
Journal: CANCER RESEARCH AND TREATMENT
Volume: ,
Medium Impact2007
1 publicationTransthoracic Echocardiographic Detection, Differential Diagnosis, and Follow-Up of Esophageal Hematoma
Im E, Shim CY, Hwang HJ, Lee SY, Yang WI, Jung YS, Kim HR, Choi EY, Ha JW, Chung N
Journal: KOREAN CIRCULATION JOURNAL
Volume: ,
Low ImpactResearch Impact
Citations
Our research has been cited over 2,500 times, demonstrating significant impact in the field.
Awards
Multiple publications have received best paper awards and recognition from professional societies.
Global Reach
Collaborations with researchers from over 15 countries, fostering international scientific exchange.
Complete Publication List
For the most up-to-date list of publications and citation metrics, please visit our Google Scholar profile.
View Google Scholar Profile